Herskowitz Neil

Average Profitability
75.59%
Insider Buys Quantity
27
Insider Buys Sum
$440,364.74
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Herskowitz Neil

The largest purchase of all time was on 2020-02-25 and amounted to 10000 shares of Avenue Therapeutics, Inc. for $93,100.

Biography of Herskowitz Neil

No biography is available at this moment.

2021-05-06PurchaseAvenue Therapeutics, Inc.
ATXI
director
2,500
0.0142%
$3.99$9,975-68.56%
2020-02-27PurchaseAvenue Therapeutics, Inc.
ATXI
director
2,400
0.0139%
$8.20$19,680+3.72%
2020-02-26PurchaseAvenue Therapeutics, Inc.
ATXI
director
161
0.001%
$8.73$1,406+0.45%
2020-02-25PurchaseAvenue Therapeutics, Inc.
ATXI
director
10,000
0.0629%
$9.31$93,100-0.89%
2019-06-18PurchaseAvenue Therapeutics, Inc.
ATXI
director
2,000
0.0126%
$5.83$11,660+21.09%
2019-06-17PurchaseAvenue Therapeutics, Inc.
ATXI
director
3,000
0.0182%
$5.88$17,640+15.92%
2019-04-15PurchaseAvenue Therapeutics, Inc.
ATXI
director
1,000
0.0061%
$4.52$4,520+33.63%
2019-03-29PurchaseAvenue Therapeutics, Inc.
ATXI
director
1,400
0.011%
$5.11$7,154+26.95%
2019-03-28PurchaseAvenue Therapeutics, Inc.
ATXI
director
600
0.0044%
$5.11$3,066+17.91%
2019-02-25PurchaseAvenue Therapeutics, Inc.
ATXI
director
5,000
0.0378%
$5.46$27,300+12.67%
2019-02-05PurchaseAvenue Therapeutics, Inc.
ATXI
director
1,850
0.0128%
$5.77$10,675-3.22%
2019-02-04PurchaseAvenue Therapeutics, Inc.
ATXI
director
7,000
0.0505%
$5.91$41,370-1.59%
2019-01-30PurchaseAvenue Therapeutics, Inc.
ATXI
director
650
0.0045%
$5.91$3,842-5.71%
2019-01-29PurchaseAvenue Therapeutics, Inc.
ATXI
director
8,553
0.0623%
$5.91$50,548-0.59%
2019-01-28PurchaseAvenue Therapeutics, Inc.
ATXI
director
1,447
0.0104%
$5.84$8,450-0.42%
2018-11-23PurchaseMustang Bio, Inc.
MBIO
director
1,000
0.0002%
$3.96$3,960-17.11%
2018-04-25PurchaseAvenue Therapeutics, Inc.
ATXI
director
1,000
0.0094%
$3.80$3,800+5.32%
2017-10-17PurchaseAvenue Therapeutics, Inc.
ATXI
director
1,000
0.0097%
$5.01$5,010-23.94%
2017-10-09PurchaseAvenue Therapeutics, Inc.
ATXI
director
500
0.0051%
$5.24$2,620-22.85%
2012-12-06PurchaseTG Therapeutics, Inc.
TGTX
director
1,000
0.0049%
$2.00$2,000+168.29%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.